BACKGROUND: The gold standard for diagnosis of enteric fever caused by Salmonella Typhi or Salmonella Paratyphi A or B is bone marrow culture. However, because bone marrow aspiration is highly invasive, many hospitals and large health centers perform blood culture instead. As blood culture has several limitations, there is a need for novel typhoid diagnostics with improved sensitivity and more rapid time to detection. METHODS: We developed a clyA-based real-time polymerase chain reaction (qPCR) method to detect Salmonella Typhi and Salmonella Paratyphi A simultaneously in blood. The sensitivity and specificity of this probeset was first evaluated in vitro in the laboratory and then in a typhoid-endemic population, in Karachi, Pakistan, and in healthy US volunteers. RESULTS: We optimized a DNA extraction and real-time PCR-based method that could reliably detect 1 colony-forming unit/mL of Salmonella Typhi. The probe set was able to detect clinical Salmonella Typhi and Salmonella Paratyphi A strains and also diarrheagenic Escherichia coli, but not invasive E. coli or other invasive bacteria. In the field, the clyA qPCR diagnostic was 40% as sensitive as blood culture. However, when qPCR-positive specimens were considered to be true positives, blood culture only exhibited 28.57% sensitivity. Specificity was ≥90% for all comparisons and in the healthy US volunteers. qPCR was significantly faster than blood culture in terms of detection of typhoid and paratyphoid. CONCLUSIONS: Based on lessons learned, we recommend that future field trials of this and other novel diagnostics that detect typhoidal and nontyphoidal Salmonella employ multiple methodologies to define a "positive" sample.
BACKGROUND: The gold standard for diagnosis of enteric fever caused by Salmonella Typhi or Salmonella Paratyphi A or B is bone marrow culture. However, because bone marrow aspiration is highly invasive, many hospitals and large health centers perform blood culture instead. As blood culture has several limitations, there is a need for novel typhoid diagnostics with improved sensitivity and more rapid time to detection. METHODS: We developed a clyA-based real-time polymerase chain reaction (qPCR) method to detect Salmonella Typhi and Salmonella Paratyphi A simultaneously in blood. The sensitivity and specificity of this probeset was first evaluated in vitro in the laboratory and then in a typhoid-endemic population, in Karachi, Pakistan, and in healthy US volunteers. RESULTS: We optimized a DNA extraction and real-time PCR-based method that could reliably detect 1 colony-forming unit/mL of Salmonella Typhi. The probe set was able to detect clinical Salmonella Typhi and Salmonella Paratyphi A strains and also diarrheagenic Escherichia coli, but not invasive E. coli or other invasive bacteria. In the field, the clyA qPCR diagnostic was 40% as sensitive as blood culture. However, when qPCR-positive specimens were considered to be true positives, blood culture only exhibited 28.57% sensitivity. Specificity was ≥90% for all comparisons and in the healthy US volunteers. qPCR was significantly faster than blood culture in terms of detection of typhoid and paratyphoid. CONCLUSIONS: Based on lessons learned, we recommend that future field trials of this and other novel diagnostics that detect typhoidal and nontyphoidal Salmonella employ multiple methodologies to define a "positive" sample.
Authors: Melita A Gordon; Anstead M K Kankwatira; Gershom Mwafulirwa; Amanda L Walsh; Mark J Hopkins; Christopher M Parry; E Brian Faragher; Eduard E Zijlstra; Robert S Heyderman; Malcolm E Molyneux Journal: Clin Infect Dis Date: 2010-04-01 Impact factor: 9.079
Authors: J Wain; V B Pham; V Ha; N M Nguyen; S D To; A L Walsh; C M Parry; R P Hasserjian; V A HoHo; T H Tran; J Farrar; N J White; N P Day Journal: J Clin Microbiol Date: 2001-04 Impact factor: 5.948
Authors: John Wain; To Song Diep; Phan Van Be Bay; Amanda L Walsh; Ha Vinh; Nguyen M Duong; Vo Anh Ho; Tran T Hien; Jeremy Farrar; Nicholas J White; Christopher M Parry; Nicholas P J Day Journal: J Infect Dev Ctries Date: 2008-12-01 Impact factor: 0.968
Authors: Elin Näsström; Nga Tran Vu Thieu; Sabina Dongol; Abhilasha Karkey; Phat Voong Vinh; Tuyen Ha Thanh; Anders Johansson; Amit Arjyal; Guy Thwaites; Christiane Dolecek; Buddha Basnyat; Stephen Baker; Henrik Antti Journal: Elife Date: 2014-06-05 Impact factor: 8.140
Authors: Trong T Ao; Nicholas A Feasey; Melita A Gordon; Karen H Keddy; Frederick J Angulo; John A Crump Journal: Emerg Infect Dis Date: 2015-06 Impact factor: 6.883
Authors: Claire S Waddington; Thomas C Darton; Claire Jones; Kathryn Haworth; Anna Peters; Tessa John; Ben A V Thompson; Simon A Kerridge; Robert A Kingsley; Liqing Zhou; Kathryn E Holt; Ly-Mee Yu; Stephen Lockhart; Jeremy J Farrar; Marcelo B Sztein; Gordon Dougan; Brian Angus; Myron M Levine; Andrew J Pollard Journal: Clin Infect Dis Date: 2014-02-10 Impact factor: 9.079
Authors: Thomas C Darton; Liqing Zhou; Christoph J Blohmke; Claire Jones; Claire S Waddington; Stephen Baker; Andrew J Pollard Journal: J Infect Date: 2017-01-24 Impact factor: 6.072
Authors: Dina M Alhaj-Qasem; Mohammad A I Al-Hatamleh; Ahmad Adebayo Irekeola; Muhammad Fazli Khalid; Rohimah Mohamud; Aziah Ismail; Fatin Hamimi Mustafa Journal: Diagnostics (Basel) Date: 2020-06-28
Authors: Liqing Zhou; Claire Jones; Malick M Gibani; Hazel Dobinson; Helena Thomaides-Brears; Sonu Shrestha; Christoph J Blohmke; Thomas C Darton; Andrew J Pollard Journal: PLoS One Date: 2016-03-01 Impact factor: 3.240
Authors: Thomas C Darton; Stephen Baker; Arlo Randall; Sabina Dongol; Abhilasha Karkey; Merryn Voysey; Michael J Carter; Claire Jones; Krista Trappl; Jozelyn Pablo; Chris Hung; Andy Teng; Adam Shandling; Tim Le; Cassidy Walker; Douglas Molina; Jason Andrews; Amit Arjyal; Buddha Basnyat; Andrew J Pollard; Christoph J Blohmke Journal: Front Microbiol Date: 2017-09-19 Impact factor: 5.640